NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Collections About News Help Login
Back to Results
Modulation of Immune Effector and Regulator Cells by Sunitinib: Potential for Combination Therapy in Renal Cell Carcinoma PatientsNo abstract available
Document ID
20150010410
Acquisition Source
Glenn Research Center
Document Type
Presentation
Authors
Finke, James (Cleveland Clinic Cleveland, OH, United States)
Rini, Brian (Cleveland Clinic Cleveland, OH, United States)
Ko, Jennifer (Cleveland Clinic Cleveland, OH, United States)
Rayman, Pat (Cleveland Clinic Cleveland, OH, United States)
Lindner, Dan (Cleveland Clinic Cleveland, OH, United States)
Borden, Ernie (Cleveland Clinic Cleveland, OH, United States)
Parsons-Wingerter, A. (NASA Glenn Research Center Cleveland, OH, United States)
Storkus, Walter (Paris VI Univ. France)
Cohen, Peter (Mayo Clinic Arizona, AZ, United States)
Date Acquired
June 10, 2015
Publication Date
June 11, 2012
Subject Category
Life Sciences (General)
Report/Patent Number
E-664232
Meeting Information
Meeting: Chemotherapy and the Immune Response in Cancer
Location: London
Country: United Kingdom
Start Date: June 11, 2012
Sponsors: Royal Society of Medicine
Funding Number(s)
CONTRACT_GRANT: IR&D04-5
CONTRACT_GRANT: NIH EY017529
WBS: WBS 432938.11.01.03.02.19
Distribution Limits
Public
Copyright
Public Use Permitted.

Related Records

There are no records associated with this record.
No Preview Available